earnings
IN
NASDAQ · INKT
MiNK Therapeutics, Inc.
Healthcare · Biotechnology
$11.64
Down-$0.08 (-0.73%)
Updated Sep 8, 2026, 7:32 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 58.3M
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- $8.48 – $16.98
- Volume
- 5.87K
- Avg. volume
- 28.08K
Price performance
INKT price history
1M range · 20 trading sessions · Daily adjusted prices
INKT closed at $11.64 after 20 trading sessions, up 6.30% for the selected period.
- Last close
- $11.64
- Period change
- +6.30%
- Period low
- $10.95
- Period high
- $12.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $11.16 | $11.64 | $11.16 | $11.64 | 5.87K |
| Sep 3, 2026 | $11.08 | $11.54 | $11.08 | $11.23 | 3.21K |
| Sep 2, 2026 | $11.00 | $11.42 | $10.82 | $11.33 | 8.26K |
| Sep 1, 2026 | $11.02 | $11.35 | $10.95 | $10.95 | 2.24K |
| Aug 31, 2026 | $11.51 | $11.75 | $10.95 | $11.09 | 11.88K |
| Aug 28, 2026 | $11.325 | $11.45 | $11.06 | $11.4282 | 6.95K |
| Aug 27, 2026 | $11.60 | $11.7995 | $11.455 | $11.68 | 4.7K |
| Aug 26, 2026 | $11.29 | $11.79 | $11.29 | $11.79 | 9.03K |
| Aug 25, 2026 | $11.26 | $11.80 | $11.04 | $11.38 | 9.35K |
| Aug 24, 2026 | $12.24 | $12.24 | $11.51 | $11.82 | 8.12K |
| Aug 21, 2026 | $11.64 | $12.20 | $11.22 | $12.20 | 11.78K |
| Aug 20, 2026 | $11.10 | $11.70 | $10.98 | $11.62 | 11.35K |
| Aug 19, 2026 | $11.84 | $12.0899 | $11.00 | $11.13 | 14.46K |
| Aug 18, 2026 | $11.01 | $12.00 | $11.01 | $12.00 | 10.59K |
| Aug 17, 2026 | $11.15 | $11.49 | $11.0612 | $11.22 | 7.83K |
| Aug 14, 2026 | $11.10 | $11.50 | $10.9501 | $11.27 | 6.79K |
| Aug 13, 2026 | $11.29 | $11.32 | $10.82 | $11.00 | 8.61K |
| Aug 12, 2026 | $11.06 | $11.60 | $11.06 | $11.36 | 4.72K |
| Aug 11, 2026 | $10.95 | $11.5587 | $10.95 | $11.23 | 5.92K |
| Aug 10, 2026 | $10.96 | $10.96 | $10.80 | $10.95 | 5.14K |
Latest INKT news
The latest Smart Investors Daily articles mentioning INKT.
Stock researchResearch & News · Analysis
Loading stock research…

